Harold J. Burstein MD, PhD | Authors


Improving Tolerance of AIs: Predicting Risk and Uncovering Mechanisms of Musculoskeletal Toxicity

November 01, 2008

Endocrine therapy plays a critical role in the management of early-stage hormone receptor–positive breast cancer, providing a nearly 50% reduction in the risk of distant and local recurrence.